ACUTE INVASIVE ASPERGILLOSIS TREATMENT MARKET ANALYSIS

Acute Invasive Aspergillosis Treatment Market, by Drug Type (Antifungals (Voriconazole, Capsofungin, Itraconazole, Isavuconazole, Amphotericin B, and Others) Corticosteroids (Prednisolone, Prednisone, and Methylprednisolone)), by Distribution Channel (Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies), and by Geography - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2022-2028

To Be Published : Nov 2024
Code : CMI1520
Formats :
Excel and PDF
Industry : Pharmaceutical

Leading Companies

Key players operating in the global acute invasive aspergillosis treatment market include GlaxoSmithKline, Mylan Pharmaceuticals, Inc., Novartis AG, Abbott laboratories, Eli Lilly and Company, AstraZeneca Plc, Pfizer, Inc., Johnson & Johnson, Takeda Pharmaceutical Company Ltd., Astellas, and Basilea Pharmaceutica International Ltd.